The practical use of cytology for diagnosis in dermatology

Eleonora Ruocco(University of Campania "Luigi Vanvitelli"), Vincenzo Ruocco(Tel Aviv University), Michele Del Vecchio(Fondazione IRCCS Istituto Nazionale dei Tumori), G Brunetti(University of Naples Federico II)

Journal of the European Academy of Dermatology and Venereology

June 9, 2010

10.1111/j.1468-3083.2010.03740.x

Cited by 51

Related Papers

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

|New England Journal of Medicine|2017|2.2k

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial

|The Lancet Oncology|2017|780

Interleukin-12: Biological Properties and Clinical Application

|Clinical Cancer Research|2007|606

Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial

|The Lancet Oncology|2020|530

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

|The Lancet Oncology|2017|501